UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹7404 Cr | ₹986 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 01 Jun 2004 | 05 Aug 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.82 | 2.29 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Exit load of 1% if redeemed within 1 month./365 | Exit load of 1% if redeemed within 30 days./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 6.25% | 7.57% |
| 6 Month | 19.11% | 23.58% |
| 1 Year | 47.43% | 53.17% |
| 3 Year | 18.54% | 18.51% |
| 5 Year | 30.13% | 29.33% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 17.1% | 16.08% |
| 3 Year | 43.51% | 39.42% |
| 5 Year | 81.66% | 72.32% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 26.16% | 24.89% |
| 3 Year | 53.8% | 49.21% |
| 5 Year | 80.65% | 74.74% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 0.68% | 0.62% |
| Beta | 0.91% | 0.94% |
| Alpha | 1.57% | 0.78% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Fund Manage | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.66 | 2.21 |
| Mid Cap | 35.52 | 31.32 |
| Small Cap | 20.97 | 32.72 |
| Large Cap | 41.85 | 33.75 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.66 | 0.97 |
| Healthcare | 98.34 | 97.31 |
| Financial | - | 0.13 |
| Insurance | - | 1.59 |
Top Comparisons
HDFC Arbitrage Fund - Wholesale Growth Option
3Y Returns5.83%
DSP Arbitrage Fund - Regular - Growth
3Y Returns5.72%
Invesco India - Invesco Global Equity Income Fund of Fund - Regular Plan - Growth
3Y Returns14.18%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns8.66%
SBI Short Horizon Debt Fund - Ultra Short Term Fund - Institutional Plan - Growth
3Y Returns5.53%
LIC MF Ultra Short Term Fund Regular - Growth
3Y Returns5.63%
Tata Hybrid Equity Fund- Regular Plan - Growth Option
3Y Returns14.08%
LIC MF Equity Hybrid Fund-Growth
3Y Returns12.98%